The Board of Directors consists of 8 Directors who have the primary duty the Company‘s guidance and strategic planning. The Board of Directors is also responsible for outline the Company’s general policies and guidelines and perform the duties conferred to them by the Brazilian Corporation Law.
The Board of Directors current members are:
|Guilherme Caldas Emrich||Chairman Counselor||30.04.2018|
|Guilherme Caldas Emrich
He has been in business leadership for more than 30 years. A graduate of UFMG, with several post-graduate courses in business administration in the US and Europe. Member of the Council of Science and Technology of the Presidency of the Republic and member of the Board of Fundação Dom Cabral, an institution of business and management development linked to the Kellog School of Business, Northwestern University (US) and INSEAD (France). For 7 years (until February 1999) he was the Chairman of the Board of Directors of Fundação Biominas, an incubator of biotechnology companies with 36 associates. One of the founders, former president and former chairman of the Biobrás Board of Directors (until January 2002), the fourth largest producer of insulins in the world. Honorary consul of Russia in Belo Horizonte. In addition to the positions held at Biobrás, Guilherme does not hold or hold other positions in public companies. Guilherme does not have any criminal convictions, nor has he ever been convicted, judicially or administratively, of any practice that results in his suspension or disqualification from practicing professional activities or acting in public companies.
|Ítalo Aurélio Gaetani||Counselor||30.04.2018|
|Italo Aurelio Gaetani
He graduated in Civil Engineering from UFMG in 1961. In 1963, he founded another company, Construtora Castor Ltda., A real estate construction and real estate company based in Belo Horizonte, MG, where he is president. Mr. Gaetani was Director of SINDUSCON (Union of the Civil Construction Industry in MG), was a member of the real estate commission of the Brazilian Chamber of Construction Industry. He has received several awards, among others, the FIEMG Industrial Merit Medal and the CDL-BH Commercial Merit Medal. Mr. Gaetani is one of the main shareholders of Biomm SA. Italo held the position of member of the board of directors of Biobrás until 2001, when it was incorporated by Novo Nordisk. Italo does not have any criminal convictions, nor has he ever been convicted, judicially or administratively, of any practice that results in his suspension or disqualification from practicing professional activities or acting in public companies.
|Walfrido Silvino dos Mares Guia Neto||Counselor||30.04.2018|
|Walfrido Silvino dos Mares Guia Neto
He graduated in Chemical Engineering from the School of Engineering of the Federal University of Minas Gerais in 1966. He also graduated in Business Administration from the Faculty of Economic, Administrative and Accounting Sciences of Belo Horizonte - FUMEC in 1973. He joined the Company in 1966 as one of the founding partners. He held various public positions, the last being during the government of President Luiz Inacio Lula da Silva, Minister of State for Tourism (2003-2007) and Minister - Chief of the Secretariat of Institutional Relations of the Presidency of the Republic (2007). Mr. Walfrido served as a member of the board of directors of Biobrás until 2001, when he was incorporated by Novo Nordisk and currently holds the position of vice chairman of the board of directors of Kroton Educacional. Walfrido does not have any criminal convictions, nor has he ever been condemned, judicially or administratively, for any practice that results in his suspension or disqualification from practicing professional activities or acting in public companies.
|Luiz Francisco Novelli Viana||Counselor||30.04.2018|
|Luiz Francisco Novelli Viana
Luiz Francisco is a founding partner and president of TMG Capital. Throughout the history of the fund has led several investments in the areas of Health, IT, Information Services and Telecom, Decision Analytics, Biotechnology, Media and Financial Technologies. Prior to founding TMG, Luiz Francisco was CEO of Latipart between 1995 and 1997, a holding company formed to restructure five private Brazilian companies. Previously, Mr. Viana was a founder, Chairman and CEO of BHM / Arlabank from 1988 to 1994. BHM / Arlabank was a joint venture between BHM, Mr. Viana‘s Investment Banking boutique and Arlabank, an investment consortium bank comprised of banks in the Middle East and Latin America. The company was sold to Assurance General de France (AGF) in 1994; between 1978 and 1989, Mr. Viana was a senior director and later CEO of the HM group, at that time, one of the Brazilian groups with operations in retail and wholesale, financial and credit card distribution with revenues of around U $ 1 billion. Luiz Francisco presides over and acts on various boards of companies, as well as being chairman and founder of GVCepe, a private equity research center in Brazil. Luiz Francisco is also Chairman of the advisory board of the AFECE (association that provides services for children with intellectual disabilities). Luiz Francisco has a degree in Business Administration from the Getúlio Vargas Foundation and a Master‘s Degree in Business Administration from the Harvard Business School in Boston, USA. Luiz does not have any criminal convictions, nor has he ever been convicted, judicially or administratively, of any practice that results in his suspension or disqualification from practicing professional activities or acting in public companies.
|Eduardo Augusto Buarque de Almeida||Counselor||30.04.2018|
|Eduardo Augusto Buarque de Almeida
Eduardo Buarque has been a member of TMG since its inception. At TMG, Eduardo worked in investments in the financial services sector, in addition to leading prospecting efforts in several segments and sectors of the Brazilian economy. Eduardo has an extensive consulting and executive career, having served as a consultant, management, board of directors, vice president and president of renowned national and multinational companies, including Anderson Clayton, GTE-Sylvania, Conabra (Wilson Meat Packing), São Paulo Alpargatas, Mappin and Dako (now MABE / GE). Eduardo was also Vice President and Operations Director of the Latinpart holding. In addition to his executive career, Eduardo is also an extra-career professor at EAESP / FGV, in the courses on Globalization and Product and Market Management and Marketing Strategy, from the Postgraduate courses. Eduardo holds a degree in Business Administration from Fundação Getúlio Vargas and a Master‘s degree in Business Administration (M.S.) from Southern Illinois University. Eduardo does not have any criminal convictions, nor has he ever been convicted, judicially or administratively, of any practice that results in his suspension or disqualification from practicing professional activities or acting in public companies.
|Cláudio Luiz Lottenberg||Counselor||30.04.2018|
|Cláudio Luiz Lottenberg
Cláudio Luiz Lottenberg holds a medical degree from the Paulista School of Medicine of the Federal University of São Paulo (1984), a Master‘s degree in Ophthalmology from the Paulista School of Medicine of the Federal University of São Paulo (1990) and a PhD in Medicine (Ophthalmology) from the Federal University of São Paulo (1994). He received medical residency by the Brazilian Council of Ophthalmology - CBO (1987) and improvement in Ophthalmological Emergencies by Manhathan Eye Ear and Throat (1989). He is currently a Full Member of the Brazilian Society of Ophthalmology Administration, President of the Israelita Albert Einstein Hospital, Advisor to the National Quality Foundation, Advisor to the Board of the Brazilian Council of Ophthalmology, Member of the Brazilian Society of Laser and Ophthalmology Surgery, Member of the Committee of the Federation of Industries of the State of São Paulo, Member of the University of Pittsburgh, Vice President of the Deliberative Council of the Brazil-Israel Chamber of Commerce and Industry. Cláudio does not have any criminal convictions, nor has he ever been convicted, judicially or administratively, of any practice that results in his suspension or disqualification from practicing professional activities or acting in public companies.
|Dirceu Brás Aparecido Barbano||Counselor||30.04.2018|
|Dirceu Brás Aparecido Barbano
Dirceu Brás Aparecido Barbano graduated in Pharmaceutical Sciences, in the Industrial Pharmacy modality, from Pontifica Universidade Católica de Campinas, in 1989. In 1991, he completed the Specialization in Biopharmagnostics course at the Faculty of Pharmaceutical Sciences of the University of São Paulo - USP. At the same Faculty, he attended the Master‘s Degree in Pharmaceuticals and Medicines, in which, between 1993 and 1997. He is a member of the Brazilian Institute of Corporate Governance (IBGC), participant of the Certification Program of Counselors. Member of the Board of Directors of LIFEMED Industrial de Equipamentos and the Brazilian College of Executives in Health - CBEXs. He is also a member of the Advisory Board of the Brazilian Association of High Technology for Healthcare Products - Abimed. He is a member of the Regulatory Affairs Professionals Society and is a partner of B2CD Consultoria Empresarial. In the early 2000s, he held the position of Municipal Secretary of Health of the municipality of Ibaté-SP, before going to the Ministry of Health. From April 2006 to April 2007, he held the position of Municipal Health Secretary in São Carlos- SP. Returning to the Ministry of Health in May 2007, he resumed the position of Director of the Department of Pharmaceutical Assistance of the Secretariat of Science, Technology and Strategic Inputs. In October 2008, he was appointed to the position of Director of the National Sanitary Surveillance Agency. In December of the same year he was appointed to serve as substitute for the Chief Executive Officer. Finally, in April 2011, he was appointed to the position of Chief Executive Officer of ANVISA. In October 2011 he was reappointed to the position of Chief Executive Officer of the agency for a further term of three years, ending on October 12, 2014.
Last Update on June 23, 2021